Skip to content
SABS SAB Biotherapeutics, Inc. Common Stock
$3.02 -16.22% -0.60
Notify me if price changes either direction
Interactive Brokers Logotype

Buy SABS stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 30.1M
Enterprise value 4.2M
Trailing PE -0.40575914982102
Forward PE -1.1897811
PEG Ratio -1.1897811
Enterprise to EBITDA -0.09
Enterprise to revenue 2.781
Price to book MRQ 0.8154077
Price to sales TTM 19.889576

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-06-30
Revenue (TTM) 1.5M
EBITDA -46911196
Diluted EPS TTM -6.16
Total Cash (MRQ) 30.4M
Current ratio (MRQ) 3.691
Operating Cash Flow (TTM) -38206536

SABS trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent SABS News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.